Bisphenol A

Study by University of Newcastle and HMRI researchers finds BPA exposure, even at 'safe' levels, poses significant female fertility risks. BPA-free labels may not be reliable, as BPA alternatives like BPS and BPF are also harmful. BPA is commonly used in food and drink packaging, and leaching occurs when heated, transferring to food or drink. High BPA levels in pregnant women's urine are linked to preterm birth, allergic diseases, and autism in children. Long-term adult risks include obesity, heart disease, and kidney disease.

Nearly all pregnant women ingest the fungal toxin zearalenone, which mimics estrogen and may disrupt reproduction, according to a study by Rutgers and University of Rochester researchers. Zearalenone was detected in 97% of urine samples from pregnant women, with higher levels found in those consuming more ultraprocessed foods. The study suggests that reducing ultraprocessed food intake could minimize exposure.

An NIEHS-supported study by Million Marker and University of Nevada researchers aimed to reduce participants' exposure to endocrine-disrupting chemicals (EDCs) through improved environmental health literacy. Participants' EDC levels were measured via urinalysis, and personalized reports detailing health effects and exposure reduction methods were provided. The study, published in July 2024, found that participants successfully used the information to reduce EDC exposure, with notable reductions in phthalates detected in urine samples post-intervention.

Food packaging and plastic tableware contain toxic chemicals absorbed by humans, posing a public health risk. A new study identified over 3,600 chemicals in food-related materials, including 189 linked to breast cancer. The FDA, criticized for insufficient oversight, is now vowing to overhaul its review processes. However, budget constraints and industry influence may hinder progress. Chemicals like BPA and PFAS are particularly concerning, with widespread health impacts. Nonprofit organizations advocate for stricter regulations, urging the FDA to prioritize public health.